These genetic mutations implicate pathways often dysregulated in cancer, including KRAS, TGFβ, WNT, NOTCH, ROBO/SLT, G1/S, SWI-SNF, and chromatin/DNA/RNA modification and repair. Here, KRAS is linked to cancer.